Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 3 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
TP53 disruptive mutation predicts platinum-based chemotherapy and PD-1/PD-L1 blockade response in urothelial carcinoma.
J Pathol. 2024 Jun;263(2):139-149. doi: 10.1002/path.6266. Epub 2024 Feb 21.
J Pathol. 2024.
PMID: 38380548
Immune inactivation by VISTA predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer.
Li W, Liu Z, Jin K, Shao F, Zeng H, Wang Y, Zhu Y, Xu L, Wang Z, Chang Y, Zhang W.
Li W, et al.
BMC Cancer. 2023 Jul 14;23(1):661. doi: 10.1186/s12885-023-11157-x.
BMC Cancer. 2023.
PMID: 37452272
Free PMC article.
Item in Clipboard
POLQ identifies a better response subset to immunotherapy in muscle-invasive bladder cancer with high PD-L1.
Liu G, Jin K, Liu Z, Su X, Xu Z, Li B, Xu J, Chang Y, Wang Y, Zhu Y, Xu L, Xu J, Wang Z, Liu H, Zhang W.
Liu G, et al.
Cancer Med. 2024 Feb;13(4):e6962. doi: 10.1002/cam4.6962.
Cancer Med. 2024.
PMID: 38457207
Free PMC article.
Item in Clipboard
Integration of CD4+ T cells and molecular subtype predicts benefit from PD-L1 blockade in muscle-invasive bladder cancer.
Liu G, Jin K, Liu Z, Su X, Xu Z, Li B, Xu J, Liu H, Chang Y, Zhu Y, Xu L, Wang Z, Wang Y, Zhang W.
Liu G, et al.
Cancer Sci. 2024 Apr;115(4):1306-1316. doi: 10.1111/cas.16119. Epub 2024 Feb 25.
Cancer Sci. 2024.
PMID: 38402640
Free PMC article.
Item in Clipboard
Cite
Cite